Acadian Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-282,701
Closed -$2.67M 1683
2017
Q1
$2.67M Buy
+282,701
New +$2.67M 0.01% 547
2016
Q1
Sell
-438,402
Closed -$2.69M 1543
2015
Q4
$2.69M Buy
438,402
+117,995
+37% +$723K 0.01% 524
2015
Q3
$1.84M Buy
320,407
+316,841
+8,885% +$1.81M 0.01% 566
2015
Q2
$27K Buy
3,566
+276
+8% +$2.09K ﹤0.01% 1076
2015
Q1
$20K Buy
+3,290
New +$20K ﹤0.01% 1123